BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25478010)

  • 1. FISH molecular testing in cytological preparations from solid tumors.
    Caria P; Vanni R
    Mol Cytogenet; 2014; 7():56. PubMed ID: 25478010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and quantitation by fluorescence in situ hybridization (FISH) and image analysis of HER-2/neu gene amplification in breast cancer fine-needle samples.
    Klijanienko J; Couturier J; Galut M; El-Naggar AK; Maciorowski Z; Padoy E; Mosseri V; Vielh P
    Cancer; 1999 Oct; 87(5):312-8. PubMed ID: 10536358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic ultrasound guided fine needle aspiration with fluorescence in situ hybridization analysis in 104 patients with pancreatic mass.
    Ribeiro A; Peng J; Casas C; Fan YS
    J Gastroenterol Hepatol; 2014 Aug; 29(8):1654-8. PubMed ID: 24628622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted multiprobe fluorescence in situ hybridization analysis for elucidation of inconclusive pancreatobiliary cytology.
    Vlajnic T; Somaini G; Savic S; Barascud A; Grilli B; Herzog M; Obermann EC; Holmes BJ; Ali SZ; Degen L; Bubendorf L
    Cancer Cytopathol; 2014 Aug; 122(8):627-34. PubMed ID: 24753508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interphase cytogenetics in pathology: principles, methods, and applications of fluorescence in situ hybridization (FISH).
    Werner M; Wilkens L; Aubele M; Nolte M; Zitzelsberger H; Komminoth P
    Histochem Cell Biol; 1997; 108(4-5):381-90. PubMed ID: 9387931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Testing on Cytology for Gene Fusion Detection.
    Schmitt F; Di Lorito A; Vielh P
    Front Med (Lausanne); 2021; 8():643113. PubMed ID: 34295907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations.
    Zhang FF; Arber DA; Wilson TG; Kawachi MH; Slovak ML
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2317-28. PubMed ID: 9815630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular diagnostics of cytological specimens].
    Fassunke J; Ball M; Engels M
    Pathologe; 2020 Feb; 41(1):39-45. PubMed ID: 31932945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ancillary testing in salivary gland cytology: A practical guide.
    Jo VY; Krane JF
    Cancer Cytopathol; 2018 Aug; 126 Suppl 8():627-642. PubMed ID: 30156767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridization for ETV6 gene rearrangements on destained cytological smears: Role in diagnosis of secretory carcinoma of salivary gland.
    Mahendru R; Sarma C; Kakkar A; Kumar R; Kaur K; Thakar A
    Cancer Cytopathol; 2023 Jul; 131(7):442-453. PubMed ID: 36973972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative FISH by image cytometry for the detection of chromosome 1 imbalances in breast cancer: a novel approach analyzing chromosome rearrangements within interphase nuclei.
    Truong K; Guilly MN; Gerbault-Seureau M; Malfoy B; Vielh P; Bourgeois CA; Dutrillaux B
    Lab Invest; 1998 Dec; 78(12):1607-13. PubMed ID: 9881960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current state of molecular cytogenetics in cancer diagnosis.
    Liehr T; Othman MA; Rittscher K; Alhourani E
    Expert Rev Mol Diagn; 2015 Apr; 15(4):517-26. PubMed ID: 25664836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of cytogenetics and fluorescence in situ hybridization to fine-needle aspiration in the diagnosis and subclassification of renal neoplasms.
    Roh MH; Dal Cin P; Silverman SG; Cibas ES
    Cancer Cytopathol; 2010 Jun; 118(3):137-45. PubMed ID: 20544709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of interphase cytogenetics in demonstrating specific chromosomal aberrations in solid tumors--new insights in the pathogenesis of malignant melanoma and head and neck squamous cell carcinoma.
    Poetsch M; Dittberner T; Woenckhaus C; Kleist B
    Histol Histopathol; 2000 Oct; 15(4):1225-31. PubMed ID: 11005247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common Fluorescence In Situ Hybridization Applications in Cytology.
    Savic S; Bubendorf L
    Arch Pathol Lab Med; 2016 Dec; 140(12):1323-1330. PubMed ID: 27479335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder.
    Lotan Y; Bensalah K; Ruddell T; Shariat SF; Sagalowsky AI; Ashfaq R
    J Urol; 2008 Jun; 179(6):2164-9. PubMed ID: 18423745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplex fluorescence in situ hybridization testing for anaplastic lymphoma kinase and c-ros oncogene 1 gene rearrangements on cytology smears in lung adenocarcinomas: comparative study with formalin-fixed paraffin-embedded sections.
    Nambirajan A; Rana D; Samant K; Prabakaran A; Malik P; Jain D
    J Am Soc Cytopathol; 2022; 11(3):154-164. PubMed ID: 35148960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of fluorescence in situ hybridization testing on cytology cell blocks for the definitive classification of salivary gland neoplasms.
    Darras N; Mooney KL; Long SR
    J Am Soc Cytopathol; 2019; 8(3):157-164. PubMed ID: 31097292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EUS-FNA with rescue fluorescence in situ hybridization for the diagnosis of pancreatic carcinoma in patients with inconclusive on-site cytopathology results.
    Kubiliun N; Ribeiro A; Fan YS; Rocha-Lima CM; Sleeman D; Merchan J; Barkin J; Levi J
    Gastrointest Endosc; 2011 Sep; 74(3):541-7. PubMed ID: 21752364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine cytology suspicious for urothelial carcinoma: Prospective follow-up of cases using cytology and urine biomarker-based ancillary techniques.
    Montalbo R; Izquierdo L; Ingelmo-Torres M; Galve P; Solé M; Franco A; Ribal MJ; Alcaraz A; Mengual L
    Cancer Cytopathol; 2020 Jul; 128(7):460-469. PubMed ID: 32083810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.